A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2017-06, Vol.35 (S2), p.87-88 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 88 |
|---|---|
| container_issue | S2 |
| container_start_page | 87 |
| container_title | Hematological oncology |
| container_volume | 35 |
| creator | Amengual, J.E. Lichtenstein, R. Lue, J.K. Sawas, A. Deng, C. Lichtenstein, E. Khan, K. Kim, H. Atkins, L. Turenne, I. Rojas, C. Chiuzan, C. Cremers, S. O'Connor, O.A. |
| description | |
| doi_str_mv | 10.1002/hon.2437_75 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1906638333</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1906638333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1455-981ad7827aa6cea04b9ef6d04693fe4a202ab2c965731a05c300df5addbd78233</originalsourceid><addsrcrecordid>eNp90M1OGzEQB3CrKlJT4NQXsMQFVC2M7f08Whunu6qTtbwOJSfL2Q8BAkJ3ixA3HoErr9cnwVHgymlGmt_MSH-EfhA4JQD07HJzd0pDltgk-oImBLIsIBBnX9EEaJIGQBn9hr6P4zWAn0E6Qa8cq4LXAhNcm-V0hasZVppLbrS44EZgJZc11tW8nApVlwusxbngssZzrn-LKea5Kc9Ls8J-pLgpxcLU-E9pCg8lV7Unlfb9THtZ6RU-1mf6BCuhS1UI_wib_88vuZASy9VcFdWc42NlcnlygPZ6dzN2h-91Hy1nwuRFIKtfZc5l0JAwioIsJa5NUpo4Fzedg3CddX3cQhhnrO9CR4G6NW2yOEoYcRA1DKDtI9e26-0aY_voaHf3ftj8fejGf_Z68zDc-ZeWZBDHLGVsq37uVDNsxnHoens_XN264ckSsNvsrc_evmfvNdvpx6ub7ukzaotq8bH1BgTYe6c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1906638333</pqid></control><display><type>article</type><title>A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)</title><source>Access via Wiley Online Library</source><creator>Amengual, J.E. ; Lichtenstein, R. ; Lue, J.K. ; Sawas, A. ; Deng, C. ; Lichtenstein, E. ; Khan, K. ; Kim, H. ; Atkins, L. ; Turenne, I. ; Rojas, C. ; Chiuzan, C. ; Cremers, S. ; O'Connor, O.A.</creator><creatorcontrib>Amengual, J.E. ; Lichtenstein, R. ; Lue, J.K. ; Sawas, A. ; Deng, C. ; Lichtenstein, E. ; Khan, K. ; Kim, H. ; Atkins, L. ; Turenne, I. ; Rojas, C. ; Chiuzan, C. ; Cremers, S. ; O'Connor, O.A.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.2437_75</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphocytes T ; Lymphoma ; Patients ; T-cell lymphoma</subject><ispartof>Hematological oncology, 2017-06, Vol.35 (S2), p.87-88</ispartof><rights>2017 The Authors. published by John Wiley & Sons, Ltd.</rights><rights>2017 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.2437_75$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.2437_75$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Amengual, J.E.</creatorcontrib><creatorcontrib>Lichtenstein, R.</creatorcontrib><creatorcontrib>Lue, J.K.</creatorcontrib><creatorcontrib>Sawas, A.</creatorcontrib><creatorcontrib>Deng, C.</creatorcontrib><creatorcontrib>Lichtenstein, E.</creatorcontrib><creatorcontrib>Khan, K.</creatorcontrib><creatorcontrib>Kim, H.</creatorcontrib><creatorcontrib>Atkins, L.</creatorcontrib><creatorcontrib>Turenne, I.</creatorcontrib><creatorcontrib>Rojas, C.</creatorcontrib><creatorcontrib>Chiuzan, C.</creatorcontrib><creatorcontrib>Cremers, S.</creatorcontrib><creatorcontrib>O'Connor, O.A.</creatorcontrib><title>A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)</title><title>Hematological oncology</title><subject>Lymphocytes T</subject><subject>Lymphoma</subject><subject>Patients</subject><subject>T-cell lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp90M1OGzEQB3CrKlJT4NQXsMQFVC2M7f08Whunu6qTtbwOJSfL2Q8BAkJ3ixA3HoErr9cnwVHgymlGmt_MSH-EfhA4JQD07HJzd0pDltgk-oImBLIsIBBnX9EEaJIGQBn9hr6P4zWAn0E6Qa8cq4LXAhNcm-V0hasZVppLbrS44EZgJZc11tW8nApVlwusxbngssZzrn-LKea5Kc9Ls8J-pLgpxcLU-E9pCg8lV7Unlfb9THtZ6RU-1mf6BCuhS1UI_wib_88vuZASy9VcFdWc42NlcnlygPZ6dzN2h-91Hy1nwuRFIKtfZc5l0JAwioIsJa5NUpo4Fzedg3CddX3cQhhnrO9CR4G6NW2yOEoYcRA1DKDtI9e26-0aY_voaHf3ftj8fejGf_Z68zDc-ZeWZBDHLGVsq37uVDNsxnHoens_XN264ckSsNvsrc_evmfvNdvpx6ub7ukzaotq8bH1BgTYe6c</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Amengual, J.E.</creator><creator>Lichtenstein, R.</creator><creator>Lue, J.K.</creator><creator>Sawas, A.</creator><creator>Deng, C.</creator><creator>Lichtenstein, E.</creator><creator>Khan, K.</creator><creator>Kim, H.</creator><creator>Atkins, L.</creator><creator>Turenne, I.</creator><creator>Rojas, C.</creator><creator>Chiuzan, C.</creator><creator>Cremers, S.</creator><creator>O'Connor, O.A.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201706</creationdate><title>A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)</title><author>Amengual, J.E. ; Lichtenstein, R. ; Lue, J.K. ; Sawas, A. ; Deng, C. ; Lichtenstein, E. ; Khan, K. ; Kim, H. ; Atkins, L. ; Turenne, I. ; Rojas, C. ; Chiuzan, C. ; Cremers, S. ; O'Connor, O.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1455-981ad7827aa6cea04b9ef6d04693fe4a202ab2c965731a05c300df5addbd78233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Lymphocytes T</topic><topic>Lymphoma</topic><topic>Patients</topic><topic>T-cell lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amengual, J.E.</creatorcontrib><creatorcontrib>Lichtenstein, R.</creatorcontrib><creatorcontrib>Lue, J.K.</creatorcontrib><creatorcontrib>Sawas, A.</creatorcontrib><creatorcontrib>Deng, C.</creatorcontrib><creatorcontrib>Lichtenstein, E.</creatorcontrib><creatorcontrib>Khan, K.</creatorcontrib><creatorcontrib>Kim, H.</creatorcontrib><creatorcontrib>Atkins, L.</creatorcontrib><creatorcontrib>Turenne, I.</creatorcontrib><creatorcontrib>Rojas, C.</creatorcontrib><creatorcontrib>Chiuzan, C.</creatorcontrib><creatorcontrib>Cremers, S.</creatorcontrib><creatorcontrib>O'Connor, O.A.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amengual, J.E.</au><au>Lichtenstein, R.</au><au>Lue, J.K.</au><au>Sawas, A.</au><au>Deng, C.</au><au>Lichtenstein, E.</au><au>Khan, K.</au><au>Kim, H.</au><au>Atkins, L.</au><au>Turenne, I.</au><au>Rojas, C.</au><au>Chiuzan, C.</au><au>Cremers, S.</au><au>O'Connor, O.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)</atitle><jtitle>Hematological oncology</jtitle><date>2017-06</date><risdate>2017</risdate><volume>35</volume><issue>S2</issue><spage>87</spage><epage>88</epage><pages>87-88</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.2437_75</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2017-06, Vol.35 (S2), p.87-88 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_1906638333 |
| source | Access via Wiley Online Library |
| subjects | Lymphocytes T Lymphoma Patients T-cell lymphoma |
| title | A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A04%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20PHASE%201%20STUDY%20OF%20PRALATREXATE%20PLUS%20ROMIDEPSIN%20REVEALS%20MARKED%20ACTIVITY%20IN%20PATIENTS%20WITH%20RELAPSED%20OR%20REFRACTORY%20(R/R)%20PERIPHERAL%20T%E2%80%90CELL%20LYMPHOMA%20(PTCL)&rft.jtitle=Hematological%20oncology&rft.au=Amengual,%20J.E.&rft.date=2017-06&rft.volume=35&rft.issue=S2&rft.spage=87&rft.epage=88&rft.pages=87-88&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.2437_75&rft_dat=%3Cproquest_cross%3E1906638333%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1906638333&rft_id=info:pmid/&rfr_iscdi=true |